WILLIAMS AND JENSEN, PLLC for MT PHARMA AMERICA, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE MARIE RUZINSKI BERTSCH | — |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
Medicare/Medicaid MMM
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases; matters affecting infusion therapies. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE MARIE RUZINSKI BERTSCH | — |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.